Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial

By sjmartinez • March 7, 2023

Zheng X, Gui X, Yao L, Ma J, He Y, Lou H, Gu J, Ying R, Chen L, Sun Q, Liu Y, Ho CM, Lee BY, Clemens DL, Horwitz MA, Ding X, Hao X, Yang H, Sha W. Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial. Emerg Microbes Infect. 2023 Mar 6:2187247. doi: 10.1080/22221751.2023.2187247. Epub ahead of print. PMID: 36872899.

Tags: clofazimine, Infectious Diseases, Parabolic Response Surface, Publications, pulmonary tuberculosis, Randomized clinical trial, Short-course treatment

DASC-LOT Framework and S3 Metric: A Novel Evaluation and Benchmarking Method to Assess Initiation, Duration, and Spectrum of Antimicrobial Usage at Inpatient Hospital Settings

Goto M, Imai S, Cho H, Merchant JA, Goetz MB, Perencevich EN, Alexander B, Shi Q, Holcombe A, Livorsi DJ. DASC-LOT Framework and S3 Metric:[...]

Intent to Accept a Valley Fever Vaccine for Humans and Dogs and Factors Influencing Intended Uptake: A Cross-Sectional Survey in Two Endemic Regions

Hermann JN, Kruger SE, Wodniak N, Holland J, Janosick V, Sanchez A, Zuniga-Moya JC, Brucker D, Torres B, Melo KM, Oliveros E, Kuran R, D'Assumpcao[...]

Structure and potential role of T6SS effector PdpC in Francisella tularensis intracellular lifestyle

Liu X, Clemens DL, Lee BY, Xia X, Fan H, Feng KY, Horwitz MA, Zhou ZH. Structure and potential role of T6SS effector PdpC in[...]